norfloxacin has been researched along with Joint Diseases in 3 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Joint Diseases: Diseases involving the JOINTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Norfloxacin and nalidixic acid were subcutaneously administered to rats and rabbits, orally administered to dogs, and norfloxacin was orally dosed to monkeys once a day for 7 consecutive days." | 1.28 | Toxicokinetic study of norfloxacin-induced arthropathy in juvenile animals. ( Aijima, H; Ishida, R; Kusajima, H; Machida, M; Maeda, A; Uchida, H, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagai, A | 1 |
| Miyazaki, M | 1 |
| Morita, T | 1 |
| Furubo, S | 1 |
| Kizawa, K | 1 |
| Fukumoto, H | 1 |
| Sanzen, T | 1 |
| Hayakawa, H | 1 |
| Kawamura, Y | 1 |
| Machida, M | 1 |
| Kusajima, H | 1 |
| Aijima, H | 1 |
| Maeda, A | 1 |
| Ishida, R | 1 |
| Uchida, H | 1 |
| Chevais, M | 1 |
| Reinert, P | 1 |
| Rondeau, MC | 1 |
| Tobelem, R | 1 |
| Albengres, E | 1 |
| Riant, P | 1 |
| Tillement, JP | 1 |
3 other studies available for norfloxacin and Joint Diseases
| Article | Year |
|---|---|
Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Cartilage, Articular; Ciprofloxacin; Dogs; Dos | 2002 |
Toxicokinetic study of norfloxacin-induced arthropathy in juvenile animals.
Topics: Administration, Oral; Aging; Animals; Dogs; Dose-Response Relationship, Drug; Joint Diseases; Joints | 1990 |
Critical risk/benefit analysis of pefloxacine use in children under 15 years--the problem of arthralgias.
Topics: Acidosis; Adolescent; Animals; Anti-Infective Agents; Cartilage, Articular; Child; Humans; Infant; J | 1987 |